全文获取类型
收费全文 | 888篇 |
免费 | 58篇 |
专业分类
946篇 |
出版年
2023年 | 2篇 |
2022年 | 14篇 |
2021年 | 23篇 |
2020年 | 9篇 |
2019年 | 16篇 |
2018年 | 12篇 |
2017年 | 20篇 |
2016年 | 22篇 |
2015年 | 50篇 |
2014年 | 53篇 |
2013年 | 61篇 |
2012年 | 66篇 |
2011年 | 93篇 |
2010年 | 54篇 |
2009年 | 32篇 |
2008年 | 57篇 |
2007年 | 72篇 |
2006年 | 49篇 |
2005年 | 53篇 |
2004年 | 52篇 |
2003年 | 36篇 |
2002年 | 42篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 5篇 |
1998年 | 7篇 |
1997年 | 8篇 |
1996年 | 5篇 |
1995年 | 2篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 3篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1985年 | 1篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1980年 | 2篇 |
1967年 | 1篇 |
排序方式: 共有946条查询结果,搜索用时 15 毫秒
81.
82.
Radović Jelena Suručić Relja Niketić Marjan Kundaković-Vasović Tatjana 《Molecular and cellular biochemistry》2022,477(7):1893-1903
Molecular and Cellular Biochemistry - Alchemilla viridiflora Rothm., Rosaceae is a herbaceous plant widespread in central Greece, Bulgaria, North Macedonia and Serbia with Kosovo. Liquid... 相似文献
83.
84.
85.
Perlin JR Lush ME Stephens WZ Piotrowski T Talbot WS 《Development (Cambridge, England)》2011,138(21):4639-4648
During peripheral nerve development, each segment of a myelinated axon is matched with a single Schwann cell. Tight regulation of Schwann cell movement, proliferation and differentiation is essential to ensure that these glial cells properly associate with axons. ErbB receptors are required for Schwann cell migration, but the operative ligand and its mechanism of action have remained unknown. We demonstrate that zebrafish Neuregulin 1 (Nrg1) type III, which signals through ErbB receptors, controls Schwann cell migration in addition to its previously known roles in proliferation and myelination. Chimera analyses indicate that ErbB receptors are required in all migrating Schwann cells, and that Nrg1 type III is required in neurons for migration. Surprisingly, expression of the ligand in a few axons is sufficient to induce migration along a chimeric nerve constituted largely of nrg1 type III mutant axons. These studies also reveal a mechanism that allows Schwann cells to fasciculate axons regardless of nrg1 type III expression. Time-lapse imaging of transgenic embryos demonstrated that misexpression of human NRG1 type III results in ectopic Schwann cell migration, allowing them to aberrantly enter the central nervous system. These results demonstrate that Nrg1 type III is an essential signal that controls Schwann cell migration to ensure that these glia are present in the correct numbers and positions in developing nerves. 相似文献
86.
Antitumor effect of Croatian propolis as a consequence of diverse sex-related dihydropyrimidine dehydrogenase (DPD) protein expression 总被引:1,自引:0,他引:1
87.
88.
Jensen MP Gorman-Lewis D Aryal B Paunesku T Vogt S Rickert PG Seifert S Lai B Woloschak GE Soderholm L 《Nature chemical biology》2011,7(8):560-565
Plutonium is a toxic synthetic element with no natural biological function, but it is strongly retained by humans when ingested. Using small-angle X-ray scattering, receptor binding assays and synchrotron X-ray fluorescence microscopy, we find that rat adrenal gland (PC12) cells can acquire plutonium in vitro through the major iron acquisition pathway--receptor-mediated endocytosis of the iron transport protein serum transferrin; however, only one form of the plutonium-transferrin complex is active. Low-resolution solution models of plutonium-loaded transferrins derived from small-angle scattering show that only transferrin with plutonium bound in the protein's C-terminal lobe (C-lobe) and iron bound in the N-terminal lobe (N-lobe) (Pu(C)Fe(N)Tf) adopts the proper conformation for recognition by the transferrin receptor protein. Although the metal-binding site in each lobe contains the same donors in the same configuration and both lobes are similar, the differences between transferrin's two lobes act to restrict, but not eliminate, cellular Pu uptake. 相似文献
89.
Helfand BT Mendez MG Murthy SN Shumaker DK Grin B Mahammad S Aebi U Wedig T Wu YI Hahn KM Inagaki M Herrmann H Goldman RD 《Molecular biology of the cell》2011,22(8):1274-1289
Vimentin intermediate filaments (VIF) extend throughout the rear and perinuclear regions of migrating fibroblasts, but only nonfilamentous vimentin particles are present in lamellipodial regions. In contrast, VIF networks extend to the entire cell periphery in serum-starved or nonmotile fibroblasts. Upon serum addition or activation of Rac1, VIF are rapidly phosphorylated at Ser-38, a p21-activated kinase phosphorylation site. This phosphorylation of vimentin is coincident with VIF disassembly at and retraction from the cell surface where lamellipodia form. Furthermore, local induction of photoactivatable Rac1 or the microinjection of a vimentin mimetic peptide (2B2) disassemble VIF at sites where lamellipodia subsequently form. When vimentin organization is disrupted by a dominant-negative mutant or by silencing, there is a loss of polarity, as evidenced by the formation of lamellipodia encircling the entire cell, as well as reduced cell motility. These findings demonstrate an antagonistic relationship between VIF and the formation of lamellipodia. 相似文献
90.
Nina S. Brykova Dmitriy A. Gusarov Irene V. Sokolova Valentine D. Gusarova Tatjana V. Vorobjeva Dmitry I. Bairamashvili 《Process Biochemistry》2011,46(10):2036-2043
It was shown that H1 type histones possess anticancer activity and could be utilized in therapy of acute myeloid leukemia. We developed an experimental pilot-scale technology of the recombinant histone H1.3 variant production. The downstream process includes acidic extraction of the target protein from the culture broth, ion-exchange, reversed-phase and size-exclusion chromatography, and freeze-drying. The accent was made on the reduction of bacterial endotoxin contamination of the active pharmaceutical ingredient. Highly efficient downstream strategy of the target protein depyrogenation is discussed in the paper. The developed technology allows the production of the protein with high yield (approx. 110 g per 1000 L of the culture broth) and of high purity (estimated productivity is 75–100 g/month). The activity and purity of the active pharmaceutical ingredients produced for clinical trials were confirmed by different tests including ultra performance liquid chromatography, size exclusion chromatography, ELISA, SDS–PAGE, gel-clot LAL-test. Clinical trials were started in the Russian Federation. 相似文献